TrialPediatric rheumatology online journal2020

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study.

Ingrid Herta Rotstein Grein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.